Cortisol Awakening Response Is Linked to Disease Course and Progression in Multiple Sclerosis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kern, Simone ^a   Krause, Ivonne ^a   Horntrich, Antje ^a   Thomas, Katja ^a   Aderhold, Julia ^a   Ziemssen, Tjalf ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTISOL AWAKENING RESPONSE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MULTIPLE SCLEROSIS; RELAPSE; REMISSION; SALIVA LEVEL; SELF REPORT;

ADULT; CASE-CONTROL STUDIES; CIRCADIAN CLOCKS; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PITUITARY-ADRENAL SYSTEM; SALIVA; YOUNG ADULT;

EID: 84876162620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060647     Document Type: Article

References (35)

1. Fries E, Dettenborn L, Kirschbaum C, (2009) The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol 72: 67-73.
2. Chida Y, Steptoe A, (2009) Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol Psychol 80: 265-278.
3. Buchanan TW, Kern S, Allen JS, Tranel D, Kirschbaum C, (2004) Circadian regulation of cortisol after hippocampal damage in humans. Biol Psychiatry 56: 651-656.
4. Pruessner M, Pruessner JC, Hellhammer DH, Bruce Pike G, Lupien SJ, (2007) The associations among hippocampal volume, cortisol reactivity, and memory performance in healthy young men. Psychiatry Res 155: 1-10.
5. Wust S, Federenko I, Hellhammer DH, Kirschbaum C, (2000) Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 25: 707-720.
6. Pruessner M, Hellhammer DH, Pruessner JC, Lupien SJ, (2003) Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom Med 65: 92-99.
7. Williams E, Magid K, Steptoe A, (2005) The impact of time of waking and concurrent subjective stress on the cortisol response to awakening. Psychoneuroendocrinology 30: 139-148.
8. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, et al. (2009) Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66: 617-626.
9. Desantis AS, Diezroux AV, Hajat A, Aiello AE, Golden SH, et al. (2012) Associations of salivary cortisol levels with inflammatory markers: The Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology 37: 1009-1018.
10. Reder AT, Makowiec RL, Lowy MT, (1994) Adrenal size is increased in multiple sclerosis. Arch Neurol 51: 151-154.
11. Erkut ZA, Hofman MA, Ravid R, Swaab DF, (1995) Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 62: 27-33.
12. Then Bergh F, Kumpfel T, Trenkwalder C, Rupprecht R, Holsboer F, (1999) Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 53: 772-777.
13. Grasser A, Moller A, Backmund H, Yassouridis A, Holsboer F, (1996) Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol Diabetes 104: 31-37.
14. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, et al. (1998) Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55: 66-72.
15. Gold SM, Raji A, Huitinga I, Wiedemann K, Schulz KH, et al. (2005) Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis. J Neuroimmunol 165: 186-191.
16. Kern S, Schultheiss T, Schneider H, Schrempf W, Reichmann H, et al. (2011) Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis. Psychoneuroendocrinology 36: 1505-1512.
17. Gold SM, Kruger S, Ziegler KJ, Krieger T, Schulz KH, et al. (2011) Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J Neurol Neurosurg Psychiatry 82: 814-818.
18. Ysrraelit MC, Gaitan MI, Lopez AS, Correale J, (2008) Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 71: 1948-1954.
19. Then Bergh F, Kumpfel T, Yassouridis A, Lechner C, Holsboer F, et al. (2007) Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis. Clin Endocrinol (Oxf) 66: 295-303.
20. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
21. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
22. Radloff LS, (1977) The CES-D Scale A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement 1: 385-401.
23. Hautzinger M, Bailer M (1993) Allgemeine Depressions Skala ADS. Weinheim: Beltz.
24. Schulz P, Schlotz W, (1999) The Trier Inventory for Chronic Stress (TICS): scale construction, statistical testing and validation of the scale work overload. Diagnostica 45: 8-19.
25. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH, (2003) Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28: 916-931.
26. Then Bergh F, Grasser A, Trenkwalder C, Backmund H, Holsboer F, et al. (1999) Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. J Neurol 246: 292-298.
27. Goebel MU, Baase J, Pithan V, Exton M, Saller B, et al. (2002) Acute interferon beta-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects. Psychoneuroendocrinology 27: 881-892.
28. Vinberg M, Bennike B, Kyvik KO, Andersen PK, Kessing LV, (2008) Salivary cortisol in unaffected twins discordant for affective disorder. Psychiatry Res 161: 292-301.
29. Wichers MC, Myin-Germeys I, Jacobs N, Kenis G, Derom C, et al. (2008) Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study. Psychosom Med 70: 314-318.
30. Besedovsky HO, del Rey A, (2000) The cytokine-HPA axis feed-back circuit. Z Rheumatol 59Suppl 2: II/26-30.
31. Hayashi R, Wada H, Ito K, Adcock IM, (2004) Effects of glucocorticoids on gene transcription. Eur J Pharmacol 500: 51-62.
32. Elenkov IJ, (2004) Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 1024: 138-146.
33. Nakano T, Ohara O, Teraoka H, Arita H, (1990) Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 265: 12745-12748.
34. Huo Y, Rangarajan P, Ling EA, Dheen ST, (2011) Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci 12: 49.
35. Compston A, Coles A, (2008) Multiple sclerosis. Lancet 372: 1502-1517.